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Abstract
Background:  To identify the spectrum of malignant attributes maintained outside the host
environment, we have compared global gene expression in primary breast tumors and matched
short-term epithelial cultures.
Results: In contrast to immortal cell lines, a characteristic 'limited proliferation' phenotype was
observed, which included over expressed genes associated with the TGFβ signal transduction
pathway, such as SPARC, LOXL1, RUNX1, and DAPK1. Underlying this profile was the conspicuous
absence of hTERT expression and telomerase activity, a significant increase in TβRII, its cognate
ligand, and the CDK inhibitor, p21CIP1/WAF1. Concurrently, tumor tissue and primary cultures
displayed low transcript levels of proliferation-related genes, such as, TOP2A, ANKT, RAD51, UBE2C,
CENPA, RRM2, and PLK.
Conclusions: Our data demonstrate that commonly used immortal cell lines do not reflect some
aspects of tumor biology as closely as primary tumor cell cultures. The gene expression profile of
malignant tissue, which is uniquely retained by cells cultured on solid substrates, could facilitate the
development and testing of novel molecular targets for breast cancer.
Background
In breast cancer, cell based experiments are largely con-
ducted with a few spontaneously arising cell lines from
late stages of disease that demonstrate unlimited prolifer-
ation (immortalization). However, the breadth of tumor
heterogeneity and early stages of breast tumorigenesis
remain under represented in such assays. We, and others
have adapted tissue processing and culture conditions to
enable the selective isolation and expansion of tumor cell
populations from primary breast cancer [1-9]. Closely
reflecting the biological heterogeneity and relatively
slower growth rate of malignant cells in primary tumor tis-
sue [10], in vitro tumor cell populations are highly varia-
ble at the microscopic level and generally require long
intervals between passages. The vast majority of such cul-
tures (>90%) display a finite mitotic lifespan. While
molecular changes underlying growth cessation in non-
malignant breast epithelial cultures are well studied
[reviewed in [11]], barriers to the continued proliferation
of tumor-derived cultures remain undetermined.
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In contradistinction to previous reports on the character-
istics of rare immortal cell lines developed from primary
tumors [4,5,7,8,12], we have focused on early passage
tumor cultures (that may not necessarily culminate as
immortal cell lines). This approach encompasses a
broader range of disease since <10% of primary breast
tumors spontaneously develop into immortal cell lines.
Although limited direct comparison of primary breast
tumor tissue and corresponding short-term cultures has
assisted in authenticating the malignant origin of tumor-
derived cultures [1-3,9], relatively little is known regard-
ing the degree of phenotypic and functional concordance
between malignant epithelial populations in human
breast tissue and their counterparts in vitro. In depth com-
parative analysis of such isogenic malignant cell popula-
tions could provide important insights regarding cellular
pathways that function independently of environmental
constraints, as well as the genome wide consequences of
constitutive growth arrest of breast tumor cells widely
encountered in laboratory dishes. Here we describe a
comprehensive comparison of matched samples of pri-
mary breast carcinoma tissue, and early passage tumor
cultures. We have used cDNA microarray-based global
gene expression profiling to determine common molecu-
lar phenotypes of tumor tissue and tumor-derived epithe-
lial cultures, which distinguish them from cancerous and
non-cancerous immortal cell lines.
Results
In order to ensure the propagation of tumor epithelium
without apparent contamination with fibroblasts and
other cellular components, previously described methods
including the selective release of nests of malignant cells
from the connective tissue, were used [2,3]. As illustrated
in Figure 1A, the characteristic epithelial morphology, and
microscopic heterogeneity between tumor cultures from
independent cases was observed. To confirm that these
cultures represented pure populations of epithelial cells,
indirect cytokeratin immunostaining was performed (Fig-
ure 1A). Clinical information and additional cell culture
details are listed in Table 1.
Concordant aspects of global gene expression in breast 
cancer tissue and tumor-derived cultures
Seventeen RNA samples were analyzed by cDNA microar-
rays. These were comprised of 4 cases of primary breast
tumor tissue and 1–2 matched tumor cultures, 2 addi-
tional unmatched tumor cultures, and 4 immortal breast
cell lines. Cell lines were selected to represent estrogen
receptor (ER) positive (T47D) and ER negative (SKBR3,
BT20) tumors, and non-cancerous breast epithelium
(ENUt7, ref. [13]).
Unsupervised clustering analysis of 7362 clones (4743
unique genes/ESTs) grouped the samples into three sepa-
rate clusters representing immortal cell lines, tumor tis-
sue, and tumor cultures. Figure 1B displays a cluster of
genes, which were over expressed in immortal cell lines
but under expressed in tumor tissue and tumor cultures,
while Figure 1C displays a 'mirror image' gene expression
pattern (under expressed genes in immortal cell lines,
which were over expressed in tumor tissue and tumor cul-
tures). The clusters selected for illustration represent
~90% gene correlation. The entire data set displayed addi-
tional clusters [Figure S1 – see  http://genome-www.stan-
ford.edu/breast_cancer/PTCC/].
Comparisons of large data sets as described above fre-
quently result in "significant" patterns of gene expression
by chance alone. We employed the Significance Analysis
of Microarrays (SAM) for independently verifying genes
that are differentially expressed between classes or groups
of samples. SAM analysis identified 930 clones, represent-
ing 681 unique genes/ESTs, whose expression was signifi-
cantly (>2-fold) different between group 1 comprised of
immortal cell lines, and group 2 comprised of tumor tis-
sue and tumor cultures (0.05% false discovery rate). A full
list of the differentially expressed genes is provided in
[Table S2 – see http://genome-www.stanford.edu/
breast_cancer/PTCC/]. As expected on the basis of the
similarity in gene expression observed between tumor tis-
sue and tumor cultures in the unsupervised array data
(Figure 1B,1C), these clusters were also present in the
SAM profile (Figure 1D). As shown in Figure 1E, genes
upregulated in immortal cell lines (indicated by red verti-
cal bar) reflecting significantly shorter doubling times (for
example, RFC4, CENPA, TOP2A, CCNA, MCM7, PCNA,
CDC2) were primarily those associated with the 'prolifer-
ation' cluster described by Ross et al [14]. In contrast,
upregulated transcripts in tumor tissue and tumor cultures
(Figure 1E, indicated by green vertical bar) included genes
involved in epithelial differentiation (MAL, MAFB,
RUNX1, KRT5), in the induction of apoptosis (DAPK1),
and in tumor angiogenesis, and extravasation (SPARC)
(Gene Ontology – GO annotations, ref [15]).
Primary epithelial cell cultures, in contrast to fibroblasts
and rapidly growing cell lines, undergo rapid growth
arrest in 10% fetal calf serum (FCS). This is why we, and
others have propagated cultures of primary tumor epithe-
lium in 0–5% FCS (1–9). Immortal cell lines, however,
grow optimally in 10% FCS; lower concentrations retard
growth. Therefore, to optimize growth conditions for
both, 2% FCS was chosen for primary tumor cultures and
10% FCS for cell lines. It is conceivable that an increased
concentration of FCS may account for differences in gene
expression between primary tumor cultures and immor-
talized cell lines. In this case, one would expect increased
proliferation in the primary tumor cultures at 10% FCS,BMC Genomics 2004, 5:47 http://www.biomedcentral.com/1471-2164/5/47
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A. Microscopic phenotype of primary tumor tissue and corresponding tumor-derived epithelial and stromal cell cultures Figure 1
A. Microscopic phenotype of primary tumor tissue and corresponding tumor-derived epithelial and stromal cell cultures. (1–3) 
– H & E-stained frozen sections showing histology of representative cases processed for RNA isolation and cell culture. Case 
number 061T – 1; 066T – 2; 068T – 3. Note abundant tumor cells in the samples. (4–6) – Early passage epithelial cultures; 
brightfield, 100× magnification. Note morphological variation between cultures in the context of an epithelial phenotype. (7–9) 
– abundant cytokeratin expression in the cytoplasm of cultured primary tumor cells analyzed by indirect immunofluorescence. 
Magnification – 400×. (10–12) – tumor-derived fibroblast cultures; brightfield, 100× magnification. Note morphological distinc-
tion between epithelial and stromal cells isolated from the same tissue sample. B – E. cDNA-based gene expression profiles of 
tumor tissue and tumor derived epithelial cultures. Rows represent genes, and columns represent samples. B, C – unsuper-
vised two-dimensional hierarchical clustering of 17 samples. B – cluster shows genes under expressed in primary tumor tissue 
and tumor cultures compared to immortal cell lines. C – cluster shows genes over expressed in primary tumor cultures and 
tumor tissue compared to immortal cell lines. D, E – Gene expression patterns, which distinguish between group 1, consisting 
of immortal cell lines, and group 2, consisting of primary tumor tissue and tumor cultures. D – Results of SAM analysis showing 
a thumbnail of 681 differentially expressed genes. E – SAM-identified genes which are in common with the cluster in panel B 
are shown by red vertical bar, and with the cluster in panel C are shown by green vertical bars. Color scale indicates expres-
sion level.
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when in fact, growth is severely inhibited by this
approach.
As summarized in Table 2, based on microarray expres-
sion data of 38,999 cDNA clones, the average correlation
between matched tumor tissue and short-term tumor cul-
tures (7 sets) was 0.41 (sd = 0.03) in contrast to 0.10 (sd
= 0.09) between tumor tissue and immortal cell lines (16
pairs). These correlation coefficients differed significantly
in a Mann-Whitney rank sum test (p = 0.007) demonstrat-
ing that the gene expression profile of tumor tissue was
more consistent with that of the corresponding tumor cul-
ture than it was with any of the immortal cell lines tested.
Determinants of replicative arrest in primary breast 
tumor-derived cultures
Towards the determination of specific molecular changes
underlying the finite proliferative lifespan in tumor
cultures, gene expression analysis, by QRT-PCR, was con-
ducted on an expanded set of 39 samples comprised of
Table 1: Clinical characteristics of Primary Tumors used for Gene Expression Analysis
Primary Tumor Cultures
Sample # Sample ID Age TNM Stage Tumor Grade Tumor 
histology
ER status Cell culture 
passage at 
RNA isolation
1 0 2 2 T N A N A1I D C N A3
20 4 4 T 5 0N A 3I D C N e g 2
30 4 7 T 7 9 I I 2I D C P o s 5
40 5 4 T 5 9 I V 3I D C P o s 8 ,  1 2
5 061T* 62 III 2 ILC Pos 5, 6
6 066T* 47 II 2 IDC NA 6, 7
7 068T* 52 II 1 IDC Pos 5, 6
80 7 1 T N A I I 3I D C N A 3
90 7 6 T 5 1 I I I 2I D C P o s 2
10 257T 41 IIB 3 IDC Neg 8
11 672T 60 II 3 IDC Neg 5
12 701T 59 I 1 IDC Pos 7
13 713T 77 II 3 IDC+ILC Pos 5, 7
14 1555T 38 NA 2 ILC NA 3, 4
15 1569T NA NA NA IDC NA 3, 4
16 1570T 66 IIA 2 IDC+ILC Pos 2
17 1599T* 64 I 2 IDC NA 3
18 1607T 58 I 1 IDC NA 5
19 1617T 64 III 2 IDC Pos 2
20 1620T 70 III 3 IDC Pos 2
21 1625T 80 IIB 3 IDC Pos 2
* Matched tissue samples analyzed by cDNA microarrays NA – not available; IDC – invasive ductal carcinoma; ILC – invasive lobular carcinoma ER 
– estrogen receptor; Neg – negative; Pos – positive
Table 2: Pair wise correlations between primary tumors, matched epithelial cultures, and immortal breast epithelial cell lines
Matched Primary Tumor Pair Immortal Breast Epithelial Cell Lines
Tissue Cell Culture ENUt7 SKBR3 BT20 T47D
R correlation
1599T 1599TC 0.31 0.05 0.07 0.01 0.23
061T 061TC1 0.44 0.10 0.03 0.03 0.24
061TC2 0.43
066T 066TC1 0.44 0.16 0.02 0.03 0.20
066TC2 0.39
068T 068TC1 0.50 0.12 0.05 0.00 0.27
068TC2 0.54BMC Genomics 2004, 5:47 http://www.biomedcentral.com/1471-2164/5/47
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multiple early passage epithelial cultures obtained from
16 primary breast cancers, 8 cases of normal breast epithe-
lial organoids and, 12 immortal breast epithelial cell
lines. As noted above, since genes in the proliferation clus-
ter displayed minimal expression in primary tumor cul-
tures, first we considered the possibility of growth arrest
due to a lack of telomerase activity and subsequent telom-
eric attrition. The relative expression of hTERC and hTERT
subunits of telomerase, encoding the structural RNA com-
ponent, and the component with reverse transcriptase
activity, respectively, was measured. While commonly
used immortal cell lines (T47D, MDA231) displayed sev-
eral-fold higher transcript levels for hTERT, undetectable
to minimal levels were observed in 6/8 independent pri-
mary tumor cultures (1599T, 713T, 1569T, 1570T, 1617T,
1620T). The primary tumor culture with the highest rela-
tive expression of hTERT (257T) has developed into an
immortal cell line (Figure 2A).
To confirm the functional impact of hTERC and hTERT
down regulation, telomerase activity was measured
directly by the TRAP assay. As expected, primary cultures
with detectable transcript levels, and immortal cell lines
of cancerous and non-cancerous origin displayed signifi-
cant telomerase activity, while those tumor cultures that
did not display gene expression showed no activity. In the
primary tumor sample, 257T, robust telomerase activity
was found as early as passage 8. Similarly, telomerase
activity was detectable in early passage epithelial cultures
propagated from cells isolated by mechanical dissociation
(SP – spillage), or enzymatic digestion (DIG) of the tumor
sample 054T (Figure 2B).
In the next step towards identifying the determinants of
replicative arrest, primary tumor cultures were compared
with immortal cell lines for relative expression of genes
associated with the negative regulation of the cell cycle in
general, and with epithelial cell proliferation in particular.
This analysis included 9 candidate genes in 3 signaling
pathways: (1) members of the CIP/KIP family of cyclin-
dependent kinase inhibitors (CDKIs), p21CIP1/WAF1,
p27KIP1, and p57KIP2 (2) members of the INK family of
CDKIs, p15INK4B, and p16INK4A (3) members of the TGF-β
family, TGFβI, TGFβII and the signaling receptors, TβRI,
and TβRII. As illustrated in Figure 3A, we observed that in
10/12 breast cancer cell lines, p21CIP1/WAF1 levels were 2
to138 fold lower than steady state levels in normal breast
epithelium. In contrast, 4/20 primary tumor culture sam-
ples showed this range of p21CIP1/WAF1 expression (p =
0.0003). For the CDKIs, p27KIP1, and p57KIP2, several fold
decrease in gene expression was observed in all primary
tumor cultures and most immortal cell lines as well (p =
0.04 and 0.69, respectively). Similarly, no significant dif-
ferences were apparent for p15INK4B, and p16INK4A gene
expression in the two groups (p = 0.07 and 0.39, respec-
tively). For members of the TGF-β family, while signifi-
cant differences were not observed in the expression of
TGFβI and TβRI, a median increase of 2 fold and 4 fold
were found in the expression of TGFβII  and  TβRII
respectvely. In contrast, immortal cell lines, showed a
median decrease of 7-fold for TGFβII and 4-fold for TβRII
(p = 0.0035 and 0.0011, respectively). All p values were
derived by the Mann-Whitney test.
We used MANOVA to compare expression of the 9 above-
mentioned genes in immortal cell lines, primary tumor
cultures, and normal breast epithelium. It was apparent
that the multivariate means for the 9 genes differed for
each of the 3 groups above and that both immortal lines
and primary tumor cultures differed from normal breast
epithelium (p = 0.0001) as also depicted in the hierarchi-
cal clustering dendrogram of these samples (Figure 3B). A
3-D plot of the first three principal components, which
together account for 83% of the total variation in expres-
sion in the 9-dimensional gene space, is shown in Figure
3C. This display format demonstrates that the three types
of cell samples cluster in different parts of the three
dimensional space and that primary tumor cultures and
immortal cell lines are significantly different from normal
breast and from each other in the expression of the nega-
tive growth regulators evaluated here (p = 0.0002). The
relatively large Wilks' lamda (0.271) for immortal cell
lines vs. primary tumor cultures is most likely due to the
greater spread of these groups in the 9-dimensional gene
space, while normal samples are tightly grouped together.
This finding may be related to the heterogeneity between
individual tumors.
Overall, the genes in the array-based clusters, shown in
Figure 1B and 1C, could be categorized as positive or neg-
ative regulators of proliferation respectively according to
GO annotations. Genes such as, PCNA,  CKS1B,  TPX2,
UBE2C, CDC6, confirmed by the statistically significant
analysis of microarray data, SAM, were among the positive
proliferation genes differentially expressed by immortal
cell lines, and matched tumor tissue/cell culture samples
(Figure 1E, also see Table S2 – http://genome-www.stan-
ford.edu/breast_cancer/PTCC/, for full list). Expression
levels of negative proliferation genes identified in the SAM
data, such as, TβRII, and CDKN1A  (p21CIP1/WAF1) were
confirmed by QRT-PCR (Figure 3A)
Discussion
The cDNA microarray analysis of primary breast tumors
and their epithelial counterparts propagated in cell culture
has revealed close similarities in the expression of several
hundred genes. Notably, increased expression of genes
deemed to be 'growth limiting' by virtue of their
consistent down regulation in immortal cell lines, was
observed. The patterns of gene up regulation or downBMC Genomics 2004, 5:47 http://www.biomedcentral.com/1471-2164/5/47
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regulation were remarkably consistent in independent
immortal lines (including those derived from non
cancerous breast epithelial cells) as was the contrasting
gene 'signature' in cultures derived from independent
A. QRT-PCR analysis of hTERT and hTERC in primary tumor cultures compared to levels in normal breast organoids, matched  fibroblasts, and immortal breast epithelial cell lines (T47D, MDA231, and ENUt7) Figure 2
A. QRT-PCR analysis of hTERT and hTERC in primary tumor cultures compared to levels in normal breast organoids, matched 
fibroblasts, and immortal breast epithelial cell lines (T47D, MDA231, and ENUt7). The Y-axis is minimized to display the range 
of relative gene expression. The highest hTERT expression level, denoted by the asterisk, was 22-fold (sample 257T). B. TRAP 
assay measurement of telomerase activity shown with, and without heat inactivation of cell lysates. Extracts equivalent to 1000 
cells are displayed. IC – internal PCR control. For sample 054T, 2 independent fractions of the tumor are shown; SP – mechan-
ically dissociated spillage, DIG – enzymatically digested tissue.BMC Genomics 2004, 5:47 http://www.biomedcentral.com/1471-2164/5/47
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Comparative QRT-PCR analysis of genes encoding negative regulators of cell proliferation in primary tumor cultures and  immortal cell lines Figure 3
Comparative QRT-PCR analysis of genes encoding negative regulators of cell proliferation in primary tumor cultures and 
immortal cell lines. A – Expression levels of individual genes represented as fold increase or decrease over gene expression in 
normal breast organoids (average of 8 independent reduction mammoplasty cases). Data shown are averages of triplicate 
measurements. Dots represent immortal cell lines (red) and primary tumor cultures (black) shown in panels B and C. B – mul-
tivariate analysis of data in A displayed as a hierarchical clustering dendrogram. The scale shows the distance between groups 
comprised of normal breast, primary tumor cultures, and immortal cell lines. For samples 1569T, 1555T, 713T, and 054T, gene 
expression was analyzed in epithelial cells at 2 different passages in culture (passage number indicated as 3', 4', 5' etc.) C – a 
plot of 3 principal components (U1, U2, and U3) of 9-dimensional space, representing the 9 genes evaluated in samples in pan-
els A and B. Based on its level of gene expression, a place is assigned to each cell sample in this space. Data points representing 
epithelial organoids from the normal breast (pink) appear to be tightly clustered, whereas those representing primary breast 
tumor cultures (green) and immortal cancer cell lines (blue) show considerable scatter.
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cases of breast carcinoma. Together, these observations
have led us to conclude that the continuous selection of
rapidly proliferating cells culminating in the
immortalized phenotype favors the loss of several aspects
of gene expression retained by early passage primary
tumor cultures.
Our data suggests that the limited growth potential of pri-
mary tumor cultures results from two major proliferative
barriers, (a) telomerase inactivation, potentially leading
to telomere attrition, and (b) negative growth signaling by
upregulated TGFβ  resulting in a significant increase in
transcription of the CDKI, p21CIP1/WAF1, consistent with
the findings of induction or stabilization of this gene in a
variety of immortalized cells exposed to exogenous TGFβ
[16,17]. Elevated levels of p21CIP1/WAF1 in turn appear to
have a direct impact on telomerase regulation [18]. As
expected of slow growing primary breast tumors, in vivo,
p21CIP1/WAF1 positive cells are detected in the majority of
cases [19]. Also pertinent in this regard is the fact that sub-
strate induced changes in cell shape upregulate TGFβ tran-
scription [20]. Since the promoter region of the TGFβ gene
contains a shear stress response element [21,22], it seems
likely that TGFβ induction occurs in response to unknown
stresses in the in vitro environment and initiates a cascade
of growth inhibitory events, including telomerase inacti-
vation. While epithelial cells derived from most primary
breast tumors rapidly revert to regulated growth dictated
by environmental signals, immortal breast epithelial cells
are insensitive to such cues, which may be the underlying
basis for their continued selection in vitro. Notably, loss or
functional inactivation of the cognate receptor often ena-
bles tumor cells in vivo to overcome the growth inhibitory
effect of TGFβ early in tumorigenesis, however, during
metastatic progression, autocrine TGFβ appears to play a
tumor-promoting role, possibly enabling tumor cells to
survive significant changes in microenvironment [23]. In
this light, induction of TGFβ in response to the in vitro
environment in primary breast tumor cultures portrays a
critical phase of tumor progression. Additionally, towards
the full manifestation of differentiated phenotypes in pri-
mary tumor cultures, cell propagation in a three-dimen-
sional growth matrix, pioneered by Bissell and colleagues
[24], is imperative. Such studies are currently ongoing in
our laboratory.
Tumor-derived immortal cell lines generally display
robust proliferation and have thus filled an important
need for functional cancer cell model systems. While
immortal cell lines continue to provide molecular and
biological insights regarding proliferation-related hall-
marks of malignancy, their functional application as indi-
cators of efficacy in cancer drug development is relevant
mostly to rapidly proliferating high-grade tumors. Many
breast tumors do not fall into this category, and are not
necessarily indolent. Thus, additional targets in diverse
gene clusters must be identified for novel drug designing.
In fact, such targets could be applicable to tumors at early
or late stages as recent studies suggest that genes
conferring invasive and/or metastatic characteristics late
in progression often become dysfunctional at earlier
stages of tumorigenesis [25]. Moreover, since our data
demonstrate that primary tumor cultures routinely
derived from surgical discard tissue display phenotypic,
and most likely functional aspects of breast cancer, they
provide a strong rationale for the experimental manipula-
tion of such cells towards revealing the causative role of
genetic polymorphisms in cancer susceptibility, an impor-
tant goal which is unlikely to be fulfilled with currently
used model systems.
Conclusions
This microarray-based analysis demonstrates that epithe-
lial cultures isolated from primary breast tumors retain
phenotypes of the malignant tissue, which are eliminated
during the selection of rapidly proliferating cell popula-
tions that comprise commonly used in vitro model sys-
tems. Thus the opportunity for basic and clinical
application of functional cells derived from the full range
of pathological breast tissue, instead of a few immortal
cell lines should not be missed.
Methods
Clinical specimens and cell culture
Pathologically confirmed tumor tissue and non malig-
nant reduction mammoplasty samples were collected as
fresh specimens under IRB approved guidelines at the Cal-
ifornia Pacific Medical Center, San Francisco, Stanford
University, and the University of California, San Francisco
between 1997 – 2000. Additional tumor samples were
obtained from the NCI Cooperative Human Tissue Net-
work. A portion of the tissue was snap frozen and cryop-
reserved for histological confirmation and nucleic acid
isolation prior to cell culture. Tumor samples were proc-
essed as previously described [2,3]. A total of 21 inde-
pendent cultured specimens were used for gene
expression analysis. Primary tumor cultures and the non-
tumorigenic, ENUt7 cell line were propagated in low cal-
cium MCDB170 medium supplemented with 2% FCS.
Breast cancer cell lines were cultured in the recommended
growth media supplemented with 10%FCS; MCF7, BT20,
MDA231, MDA157 in DME-H21; BT474, CAMA1, T47D,
ZR75 in RPMI 1740; MDA435, MDA134, MDA361 in L15.
To confirm the epithelial phenotype of primary tumor
derived cells, cultures fixed with 50% ethanol: acetone
were immunostained with anti pan-cytokeratin, as previ-
ously described [1].BMC Genomics 2004, 5:47 http://www.biomedcentral.com/1471-2164/5/47
Page 9 of 10
(page number not for citation purposes)
RNA isolation, microarray methods and data analysis
Frozen tissue was trimmed to yield >90% tumor cell
enrichment. Total RNA was extracted with the RNAeasy
Mini kit (Qiagen), amplified using an optimized T7 based
protocol [26], labeled with Cy5, and hybridized to
~47,000 feature cDNA microarrays as previously
described [26,27]. Hybridized arrays were scanned (Axon)
and images were analyzed using GenePix® Pro 4.0 soft-
ware (Axon Instruments). Spots were selected for analysis
if signal intensities in both Cy3 and Cy5 channels were
2.5 times higher than background. The arrays were clus-
tered using a hierarchical clustering algorithm [28], which
groups genes and samples on the basis of their expression
similarities. The results were visualized using TreeView
software [29]. The clustering was performed on clones
whose expression varied at least 3-fold from the mean in
one or more samples and was measurable in over 80% of
the samples.
Significance Analysis of Microarrays [30,31], used for
identifying genes whose expression differed significantly
between groups, was performed on data from 38,999
cDNA clones. After the selection of spots 2.5 times over
background, and the elimination of clone redundancy,
data was retrieved on 930 clones, representing 681 unique
genes.
Quantitative Real Time PCR (QRT-PCR)
RNA samples were treated with RNAse-free DNAse
(Roche) to remove genomic DNA, and reverse tran-
scribed. Fifty ng of cDNA was used as template for PCR
amplification with specific oligonucleotide primers,
(designed using Primer Express 1.5 software). Following
denaturation and cycling reactions (40 cycles) the prod-
ucts were analyzed (Applied Biosystems 5700 Sequence
Detection System). The cycle number at which the
amount of amplified target reached a fixed threshold was
designated as the threshold cycle (CT). The higher the ini-
tial amount of transcript template, the lower the CT value.
For quantitation of gene expression, the target gene value
normalized to the expression of an endogenous reference
(β actin) was designated as ∆CT. Relative gene expression
was calculated by the formula 2-∆∆CT. ∆∆CT was obtained
by subtracting the ∆CT of test sample from the ∆CT of nor-
mal breast epithelial fractions, called 'organoids', isolated
from mechanically and enzymatically dissociated reduc-
tion mammoplasty tissue (average of 8 independent
specimens).
Telomerase activity
Cell lysates prepared from primary tumor cultures,
immortal cell lines, and normal breast organoids were
analyzed by the telomerase repeat amplification protocol
(TRAP) as per manufacturer recommendation (Intergen).
Briefly, trypsinized cell pellets were resuspended in lysis
buffer at 500 cells/microliter, incubated on ice for 30 min-
utes, centrifuged at 12,000 × g for 20 mins, and the telom-
erase containing supernatant used for PCR amplification.
Reaction products were resolved in 10% PAGE gels and
visualized with SYBR Green-1 (Molecular Probes). Heat
inactivated controls were included for each sample. Line-
arity of the assay was determined with cell dilutions rang-
ing from 100 to 10, 000 cells.
Statistical methods
We calculated Pearson correlations from the microarray
data generated from 38,999 clones to measure similarities
among 7 matched tumor tissue: cell culture sample pairs
and among 16 tumor tissue: immortal cell line pairs. For
QRT-PCR data, multivariate analysis of variance
(MANOVA) was used to compare the expression levels of
genes involved in negative growth regulation between
immortal cell lines, primary tumor cultures, and non
malignant breast epithelial cells. Tests for statistical signif-
icance were based on Wilks lamda criterion, a multivariate
analog of the F-test for univariate analysis of variance
(ANOVA), which tests the equality of means. Calculations
were made in Data Desk, version 6.2. Principal compo-
nents for all genes over all the data were computed and S-
Plus was used to plot the data for the first 3 principal
components.
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